Your browser doesn't support javascript.
loading
Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
Kaur, Harparkash; Allan, Elizabeth Louise; Mamadu, Ibrahim; Hall, Zoe; Ibe, Ogochukwu; El Sherbiny, Mohamed; van Wyk, Albert; Yeung, Shunmay; Swamidoss, Isabel; Green, Michael D; Dwivedi, Prabha; Culzoni, Maria Julia; Clarke, Siân; Schellenberg, David; Fernández, Facundo M; Onwujekwe, Obinna.
Afiliação
  • Kaur H; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom.
  • Allan EL; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom.
  • Mamadu I; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, Tavistock Place, London, United Kingdom.
  • Hall Z; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom.
  • Ibe O; Department of Pharmacology and Therapeutics, University of Nigeria, Enugu, Nigeria.
  • El Sherbiny M; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, Tavistock Place, London, United Kingdom.
  • van Wyk A; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom.
  • Yeung S; Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, Tavistock Place, London, United Kingdom.
  • Swamidoss I; Division of Parasitic Diseases and Malaria, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Green MD; Division of Parasitic Diseases and Malaria, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Dwivedi P; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Culzoni MJ; Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Santa Fe, Argentina.
  • Clarke S; Department of Disease Control, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom.
  • Schellenberg D; Department of Disease Control, London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom.
  • Fernández FM; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
  • Onwujekwe O; Department of Pharmacology and Therapeutics, University of Nigeria, Enugu, Nigeria.
PLoS One ; 10(5): e0125577, 2015.
Article em En | MEDLINE | ID: mdl-26018221
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antimaláricos Tipo de estudo: Clinical_trials / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antimaláricos Tipo de estudo: Clinical_trials / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article